Showing 271-280 of 308 results for "".
- Demystified: Your Insurance Coverage During COVID-19https://modernaesthetics.com/news/demystified-your-insurance-coverage-during-covid-19/2472913/Jason O’Dell, a financial consultant and insurance specialist at OJM Group, spoke with New Jersey-based dermatologist Jeanine Downie, MD and Chicagoland facial plastic surgeon Steve Dayan, MD about what to expect from insurance coverage during the pandemic and how to beef up your policies i
- Results of Phase 2 Study Demonstrate Safety and Efficacy of Galderma's Proprietary Liquid Toxinhttps://modernaesthetics.com/news/results-of-phase-2-study-demonstrate-safety-and-efficacy-of-galdermas-proprietary-liquid/2472827/Results of a Phase 2 study show Galderma’s novel liquid abotulinum toxin, QM1114, is safe and effective for the treatment of glabellar lines. Galderma is now poised to advance to Phase 3 testing of the liquid formulation of botulinum toxin type A for the treatment of glabellar lines. The tr
- Back by Popular Demand: Sciton's Bright Lights Big City BBL Tourhttps://modernaesthetics.com/news/back-by-popular-demand/2472107/Sciton. Inc.’s
- Sinclair Launches “Beauty in Balance” Immersive Event for Aesthetic Practitionershttps://modernaesthetics.com/news/sinclair-launches-beauty-in-balance-immersive-event-for-aesthetic-practitioners/2483903/Sinclair North America has announced Sinclair Insight: Beauty in Balance, a 1-day immersive event designed to explore holistic approaches to aesthetics through education and live clinical demonstration. The event will take place Saturday, October 25, from
- Dr. CI:Labo Presents New Clinical Data on Post-IPL Skincare for Asian Skin at IMCAS Asia 2025https://modernaesthetics.com/news/dr-cilabotm-presents-new-clinical-data-on-post-ipl-skincare-for-asian-skin-at-imcas-asia-2025/2475378/At IMCAS Asia 2025, Dr.CI:LABOTM presented new clinical findings demonstrating the efficacy of two of its skincare products—VC100 Essence Lotion EX and 377VC Radiance Serum—as adjuncts to Intense Pulsed Light (IPL) treatments in Asian patients. The data revealed that VC100 Esse
- Skinbetter Science Launches BioRewind Skin Health Dietary Supplement to Combat Skin Glycationhttps://modernaesthetics.com/news/skinbetter-science-launches-biorewind-skin-health-dietary-supplement-to-combat-skin-glycation/2473747/Skinbetter science launched BioRewind, a skin health dietary supplement with a purpose of visibly improving skin quality by helping reduce advanced glycation endproducts (AGEs), on Monday. Glycation is a key contributor to skin aging and this supplement’s formula is clinically demonstrate
- ASDS Abstract Examines Black Women’s Aesthetic Concernshttps://modernaesthetics.com/news/asds-abstract-examines-black-womens-aesthetic-concerns/2473705/Patients’ concerns and desires can vary based on various demographics, so understanding the interests of Black women was the focus of a top-10 abstract presented by Michelle Henry, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Henry presented
- Kenvue to Present Baby Skincare Data at Pediatrics Conferencehttps://modernaesthetics.com/news/kenvue-to-present-baby-skincare-data-at-pediatrics-conference/2473679/Kenvue Inc. will present new data demonstrating effective sleep and skin moisturization strategies for babies during the American Academy of Pediatrics (AAP) National Conference & Exhibition, set for September 27 through October 1 in Orlando, Florida. In addition to findings support
- Kenvue to Present New Data on Skincare Products at EADV Congresshttps://modernaesthetics.com/news/kenvue-to-present-new-data-on-skincare-products-at-eadv-congress/2473676/Kenvue announced the presentation of seven new data sets at the 2024 European Academy of Dermatology and Venereology (EADV) Congress this week in Amsterdam, Netherlands. The studies will feature Kenvue’s Aveeno and Neutrogena brands, “demonstrating the key to improved s
- Merz Aesthetics’ Belotero Balance (+) Receives FDA Approval for Infraorbital Hollowshttps://modernaesthetics.com/news/merz-aesthetics-belotero-balance-receives-fda-approval-for-infraorbital-hollows/2473500/The U.S. Food and Drug Administration (FDA) approved Merz Aesthetics’ Belotero Balance (+) for improvement of the infraorbital hollow (IOH) in adults over the age of 21. This approval stems from positive pivotal study results demonstrating the efficacy and safety of Belotero